fashion -WSS

fashion

author：explore 2025-10-01 19:41:31 - browse：3474

Physician groups backed by Welsh, Carson, Anderson & Stowe are looking to influence federal merger policy. Adobe

Three large and growing physician groups backed by the private equity giant Welsh, Carson, Anderson & Stowe have hired a prominent lobbying firm to influence federal policy covering mergers and acquisitions.

Over the past two weeks, United Musculoskeletal Partners, U.S. Anesthesia Partners, and U.S. Radiology Specialists each registered with Forbes Tate Partners, a lobbying shop founded by political insiders who used to work in President Bill Clinton’s administration.

The doctor groups hired Forbes Tate to lobby on “issues related to health care consolidation,” according to federal lobbying disclosures. Each company and Welsh Carson did not respond to inquiries. Forbes Tate also did not respond.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： EU regulator recommends expanding Mounjaro approval to obesity

focus

entertainment

WSS

Eli Lilly, Pfizer, and others want in on the online prescription market

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Medicare Advantage today, explained in one chart

Listen: Wegovy in the brain & pivotal Alzheimer's data

Think you might have Covid

How dance can help nurses traumatized by Covid

hotspot

fashion

Wikipedia

In Memoriam: Notable people who died in 2023

Cosmetics set for new safety regulation. Why the industry is on board

After affirmative action ruling, medical educators look to 'holistic review'

Francis Collins on trust in science and how Covid communications failed

Supreme Court strikes down use of affirmative action

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Medicare details structure of new drug price negotiation program

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Psychedelics group wrestles with new pharma identity

How dance can help nurses traumatized by Covid

focus

Prior authorization will have to move faster under new Biden rule

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Prior authorization will have to move faster under new Biden rule

Google and Epic fight stronger regulation of AI in health care

In early work, researchers turn to CRISPR to treat Alzheimer's

Dewpoint Therapeutics lays off staff after losing partnerships

focus

entertainment

Wikipedia

hotspot